AU4036578A - Creation of Inventions and Patents with Artificial Intelligence

AU4036578A – Xanthine derivatives
– Google Patents

AU4036578A – Xanthine derivatives
– Google Patents
Xanthine derivatives

Info

Publication number
AU4036578A

AU4036578A
AU40365/78A
AU4036578A
AU4036578A
AU 4036578 A
AU4036578 A
AU 4036578A
AU 40365/78 A
AU40365/78 A
AU 40365/78A
AU 4036578 A
AU4036578 A
AU 4036578A
AU 4036578 A
AU4036578 A
AU 4036578A
Authority
AU
Australia
Prior art keywords
xanthine derivatives
xanthine
derivatives
Prior art date
1977-10-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Application number
AU40365/78A
Other versions

AU521585B2
(en

Inventor
Et Al Sten Hakan Axel Magnus Bergstrand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Draco AB

Original Assignee
Draco AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1977-10-14
Filing date
1978-10-03
Publication date
1980-04-17

1978-10-03
Application filed by Draco AB
filed
Critical
Draco AB

1980-04-17
Publication of AU4036578A
publication
Critical
patent/AU4036578A/en

1982-04-22
Application granted
granted
Critical

1982-04-22
Publication of AU521585B2
publication
Critical
patent/AU521585B2/en

Status
Expired
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07D—HETEROCYCLIC COMPOUNDS

C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings

C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members

C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

C07D239/46—Two or more oxygen, sulphur or nitrogen atoms

C07D239/52—Two oxygen atoms

C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals

C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P37/00—Drugs for immunological or allergic disorders

A61P37/08—Antiallergic agents

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07D—HETEROCYCLIC COMPOUNDS

C07D473/00—Heterocyclic compounds containing purine ring systems

C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6

C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms

C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

AU40365/78A
1977-10-14
1978-10-03
Xanthine derivatives

Expired

AU521585B2
(en)

Applications Claiming Priority (2)

Application Number
Priority Date
Filing Date
Title

SE7711581A

SE416810C
(en)

1977-10-14
1977-10-14

PROCEDURE FOR THE PREPARATION OF Xanthine DERIVATIVES WITH ANTIALLERGIC ACTIVITY

SESE7711581

1977-10-14

Publications (2)

Publication Number
Publication Date

AU4036578A
true

AU4036578A
(en)

1980-04-17

AU521585B2

AU521585B2
(en)

1982-04-22

Family
ID=20332576
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

AU40365/78A
Expired

AU521585B2
(en)

1977-10-14
1978-10-03
Xanthine derivatives

Country Status (21)

Country
Link

US
(1)

US4233303A
(en)

EP
(1)

EP0001735B1
(en)

JP
(1)

JPS5479296A
(en)

AT
(1)

AT363491B
(en)

AU
(1)

AU521585B2
(en)

CA
(1)

CA1109470A
(en)

CS
(1)

CS208756B2
(en)

DD
(1)

DD139855A5
(en)

DE
(1)

DE2862017D1
(en)

DK
(1)

DK148260C
(en)

FI
(1)

FI66383C
(en)

HK
(1)

HK6385A
(en)

HU
(1)

HU180219B
(en)

IE
(1)

IE47884B1
(en)

IT
(1)

IT1109208B
(en)

NO
(1)

NO147562C
(en)

NZ
(1)

NZ188566A
(en)

SE
(1)

SE416810C
(en)

SG
(1)

SG85584G
(en)

SU
(1)

SU755199A3
(en)

ZA
(1)

ZA785335B
(en)

Cited By (1)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

AU681034B2
(en)

1994-07-19
1997-08-14
Japan Energy Corporation
1-arylpyrimidine derivatives and pharmaceutical use thereof

Families Citing this family (23)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

SE7810947L
(en)

1978-10-20
1980-04-21
Draco Ab

3-ALKYLXANTHINES

SE8002910L
(en)

1980-04-18
1981-10-19
Draco Ab

3,8-DIALKYLXANTINES, PROCEDURES FOR THEIR PREPARATION, PREPARATION AND METHODS OF TREATMENT OF CHRONIC OBSTRUCTIVE AIR DISORDER AND CARDIOVASCULAR DISEASES

US4755517A
(en)

1986-07-31
1988-07-05
Warner-Lambert Company
Derivatives of xanthine, pharmaceutical compositions and methods of use therefor

US5298508A
(en)

1988-07-19
1994-03-29
The United States Of America As Represented By The Department Of Health And Human Services
Irreversible inhibitors of adenosine receptors

GB8826595D0
(en)

1988-11-14
1988-12-21
Beecham Wuelfing Gmbh & Co Kg
Active compounds

US5321029A
(en)

1988-11-14
1994-06-14
Beecham-Wuelfing Gmbh & Co.K.G.
Xanthines

IT1229195B
(en)

1989-03-10
1991-07-25
Poli Ind Chimica Spa

XANTHINIC DERIVATIVES WITH BRONCODILATORY ACTIVITY AND THEIR THERAPEUTIC APPLICATIONS.

GB8929208D0
(en)

1989-12-27
1990-02-28
Almirall Lab
New xanthine derivatives

US5047534A
(en)

1990-03-26
1991-09-10
Merrell Dow Pharmaceuticals Inc.
Selective adenosine receptor agents

US5342841A
(en)

1992-03-12
1994-08-30
Kyowa Hakko Kogyo Co., Ltd.
Xanthine derivatives

US5366977A
(en)

1992-09-29
1994-11-22
The United States Of America, As Represented By The Department Of Health And Human Services
Method of treating cystic fibrosis using 8-cyclopentyl-1,3-dipropylxanthine or xanthine amino congeners

US5395836A
(en)

1993-04-07
1995-03-07
Kyowa Hakko Kogyo Co., Ltd.
8-tricycloalkyl xanthine derivatives

GB9312853D0
(en)

1993-06-22
1993-08-04
Euro Celtique Sa
Chemical compounds

US5922751A
(en)

1994-06-24
1999-07-13
Euro-Celtique, S.A.
Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same

US5591776A
(en)

1994-06-24
1997-01-07
Euro-Celtique, S.A.
Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV

CA2206804C
(en)

1994-12-13
2002-03-19
Euro-Celtique, S.A.
Trisubstituted thioxanthines

US6066641A
(en)

1994-12-13
2000-05-23
Euro-Celtique S.A.
Aryl thioxanthines

US6166041A
(en)

1995-10-11
2000-12-26
Euro-Celtique, S.A.
2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma

US6075016A
(en)

1996-04-10
2000-06-13
Euro-Celtique S.A.
6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity

US5864037A
(en)

1996-06-06
1999-01-26
Euro-Celtique, S.A.
Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity

RU2367442C2
(en)

2003-04-25
2009-09-20
Новокардия, Инк.
Method of urinary normalisation in renal malfunction

JP2007532671A
(en)

2004-04-16
2007-11-15
ノヴァカーディア，インク．

Combination therapy comprising an adenosine A1 receptor antagonist and an aldosterone inhibitor

US20070049757A1
(en)

2005-08-26
2007-03-01
Rieger Jayson M
Methods for the synthesis of substituted amino uracils

Family Cites Families (5)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

DE1911279A1
(en)

1969-03-05
1970-11-12
Eckert Dr Theodor

Process to increase the ability of drugs to be absorbed

US3900474A
(en)

1973-05-14
1975-08-19
Kendall & Co
Trifluoroalkyl, fluorobenzyl, pentafluorobenzyl, fluorobenzenesulfonyl, and pentafluorobenzenesulfonyl theophyllines

US4061753A
(en)

1976-02-06
1977-12-06
Interx Research Corporation
Treating psoriasis with transient pro-drug forms of xanthine derivatives

US4120947A
(en)

1976-03-31
1978-10-17
Cooper Laboratories, Inc.
Xanthine compounds and method of treating bronchospastic and allergic diseases

CA1077932A
(en)

1976-03-31
1980-05-20
Berlex Laboratories, Inc.
Xanthine compounds and method of treating bronchospastic and allergic diseases

1977

1977-10-14
SE
SE7711581A
patent/SE416810C/en
unknown

1978

1978-09-19
ZA
ZA00785335A
patent/ZA785335B/en
unknown

1978-09-29
US
US05/947,002
patent/US4233303A/en
not_active
Expired – Lifetime

1978-10-03
EP
EP78850015A
patent/EP0001735B1/en
not_active
Expired

1978-10-03
AU
AU40365/78A
patent/AU521585B2/en
not_active
Expired

1978-10-03
NZ
NZ188566A
patent/NZ188566A/en
unknown

1978-10-03
DE
DE7878850015T
patent/DE2862017D1/en
not_active
Expired

1978-10-04
AT
AT0714478A
patent/AT363491B/en
not_active
IP Right Cessation

1978-10-10
CA
CA313,026A
patent/CA1109470A/en
not_active
Expired

1978-10-12
DD
DD78208423A
patent/DD139855A5/en
unknown

1978-10-12
DK
DK453778A
patent/DK148260C/en
not_active
IP Right Cessation

1978-10-13
IE
IE2041/78A
patent/IE47884B1/en
unknown

1978-10-13
FI
FI783126A
patent/FI66383C/en
not_active
IP Right Cessation

1978-10-13
SU
SU782675299A
patent/SU755199A3/en
active

1978-10-13
HU
HU78DA359A
patent/HU180219B/en
unknown

1978-10-13
IT
IT51499/78A
patent/IT1109208B/en
active

1978-10-13
CS
CS786669A
patent/CS208756B2/en
unknown

1978-10-13
NO
NO783471A
patent/NO147562C/en
unknown

1978-10-14
JP
JP12573978A
patent/JPS5479296A/en
active
Pending

1984

1984-11-29
SG
SG855/84A
patent/SG85584G/en
unknown

1985

1985-01-24
HK
HK63/85A
patent/HK6385A/en
unknown

Cited By (1)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

AU681034B2
(en)

1994-07-19
1997-08-14
Japan Energy Corporation
1-arylpyrimidine derivatives and pharmaceutical use thereof

Also Published As

Publication number
Publication date

HU180219B
(en)

1983-02-28

SE7711581L
(en)

1979-04-14

DK453778A
(en)

1979-04-15

IT7851499D0
(en)

1978-10-13

FI66383C
(en)

1984-10-10

US4233303A
(en)

1980-11-11

FI66383B
(en)

1984-06-29

SU755199A3
(en)

1980-08-07

NO783471L
(en)

1979-04-18

CA1109470A
(en)

1981-09-22

AU521585B2
(en)

1982-04-22

SE416810C
(en)

1982-05-11

SE416810B
(en)

1981-02-09

HK6385A
(en)

1985-02-01

IT1109208B
(en)

1985-12-16

DK148260B
(en)

1985-05-20

IE782041L
(en)

1979-04-14

NO147562B
(en)

1983-01-24

JPS5479296A
(en)

1979-06-25

EP0001735A1
(en)

1979-05-02

CS208756B2
(en)

1981-09-15

IE47884B1
(en)

1984-07-11

DD139855A5
(en)

1980-01-23

NO147562C
(en)

1983-05-18

SG85584G
(en)

1985-06-07

FI783126A
(en)

1979-04-15

ATA714478A
(en)

1980-09-15

DK148260C
(en)

1986-02-10

AT363491B
(en)

1981-08-10

DE2862017D1
(en)

1982-10-28

NZ188566A
(en)

1984-07-06

ZA785335B
(en)

1979-09-26

EP0001735B1
(en)

1982-09-01

Contact information